A decade ago, science infrastructure in India was an afterthought — limited clusters built to code, rarely designed around how research actually moves from bench to scale. That has changed, and not incrementally. Pharma and biotech continue to scale, and with them, material sciences, specialty chemicals, drone and aerospace technology, semiconductors, advanced electronics, agri-biotech and space tech are all advancing at once — each arriving at the same realization: science has outgrown the shed it was built in. Each of these sectors has different needs for space, utilities, scale and capital, all converging on the same
infrastructure gap.
India’s science isn’t simply growing — it’s diversifying, and capital has started to notice both at once. We at NXT QST FWD have been building infrastructure for science’s demands at each stage, ahead of when the
need became apparent.
We continue to invest in building India’s innovation and manufacturing capability.
The Infrastructure Gap Across India’s Science Clusters
A drone tech company piloting new composite materials. A specialty chemicals business scaling a new formulation from bench to batch. A material sciences startup moving from lab-grade to production-grade output. A biotech company moving a molecule from research into GMP-grade production. None of these can operate out of generic industrial or IT-park space — science, it turns out, has very little patience for a building
that wasn’t built for it.
What they need is infrastructure that is:
- Red category approved — cleared upfront to host the full research-pilot-to-manufacturing continuum, not just early-stage R&D, so a company doesn’t hit a compliance ceiling the moment it needs to scale beyond a lab bench
- Ready-to-operate, cutting the time between occupying a space and getting science underway
- Built to the specifics of the science — F2F heights, load capacities, MEP and utilities, effluent and waste handling, sized for the process, not retrofitted around it
- Anchored in established science clusters, with access to talent, regulatory familiarity and collaborative environments built around an ecosystem of peers and partners
Red category approval is the foundation — the clearance that lets process floors, pilot lines and manufacturing share the same ecosystem as R&D, without a company relocating, re-permitting or rebuilding every time its science advances a stage further. But clearance alone isn’t the point. What it actually buys a company is room to scale: shell and core engineered with the load capacity, utility headroom and floor plates to grow into, not merely occupy. Infrastructure designed this way doesn’t ask a business to predict its fiveyear equipment list on day one — it’s agile enough to expand a pilot bay into a production floor, or a single process line into three, without a company outgrowing its facility before it’s even outgrown the opportunity. Sustainability is engineered into that same agility rather than bolted on afterward: energy, water, waste and effluent systems sized not just for today’s load but for tomorrow’s scale-up, designed in from the outset rather than retrofitted once a facility is already stretched.
Science clusters in India have grown faster than the infrastructure built to serve them, and most of what exists still assumes every occupant is operating at one fixed scale, forever. The gap isn’t a footnote. It’s room to grow into.
What Science Needs Today. What It Will Need Next.
The technical bar for science infrastructure has climbed well past four walls and a permit. Today, that means F2F heights and floor loading calculated for the equipment actually going in, not a generic industrial spec. It calls for MEP density engineered around power draw, gas lines and air-change rates that vary tenfold between a dry lab and a wet lab. Effluent and waste systems have to handle chemical and biological load,
not office plumbing with an exemption certificate. And the shell needs enough modularity that a pilot line can expand into a production floor without a company walking out the door to start over somewhere else.
Tomorrow’s demands are already visible in the sectors converging on India’s science clusters right now. A specialty chemicals company and a battery-materials company increasingly need the same cleanroom classification. A drone tech company running composite testing has power and structural demands closer to a semiconductor fab than a conventional workshop. Compute-heavy R&D — materials informatics, AIassisted
discovery, high-throughput screening — is pushing power density and cooling requirements that most existing labspace was never built to carry. And as sustainability reporting becomes as standard as fire compliance, energy and effluent systems will need to be measurable and auditable by design, not retrofitted for a disclosure deadline.
The strategic question for any science infrastructure platform is no longer just what today’s tenant needs. It’s whether the building can absorb the next five years of a sector’s technical evolution without a rebuild — and whether it was designed by people who understood that evolution before it showed up at the door.
25+ Years, One Thesis
Our track record isn’t in one product or one way of operating. It’s in reading what each phase of India’s science ecosystem needed and building ahead of that need rather than reacting to it — as companies moved from seeking operational readiness, to seeking infrastructure built around their specific science, to seeking to scale research into full manufacturing, to now, seeking to own the ground their science stands on.
That last shift is where the ecosystem is heading next. Ownership of science infrastructure — not just
occupation of it — is becoming as fundamental to how companies and investors think about labspace as it already is in commercial real estate: long-term, appreciating, structurally certain, and until recently, simply unavailable to most of the people who wanted it.
Each phase of that journey has answered a different question the market was asking: how fast can I operationalise, how closely can this be built around my process, can this scale with me, and now — can I own it.
Two Stakeholders. One Infrastructure Thesis.
Science infrastructure sits at the confluence of two distinct imperatives, and it is built to satisfy both without
asking either to compromise.
For science companies, the imperative is operational: infrastructure engineered to the specifics of the process, anchored in a cluster that already commands the talent, regulatory familiarity and ecosystem of peers a growing science business depends on. The science moves faster when the building isn’t the obstacle.
For investors, the imperative is structural: an asset class defined by long lease tenures, high fit-out spend, and retention that outperforms conventional commercial real estate — because science companies rarely relocate once a facility has been built around their process. Ownership of this infrastructure has not, until now, been available at this scale.
Two very different questions. The same infrastructure answers both.
Infrastructure Built for Where India’s Science Ecosystem Is Going
The next chapter of Indian science and manufacturing won’t be written by one sector or one city. It will be written by whether the infrastructure — compliant, ready-to-operate, scalable, and increasingly ownable — offers the flexible growth paths this ecosystem needs to keep moving.
That is the platform NXT QST FWD is building: science as our forte, and integrated science ecosystems that bring infrastructure, talent, collaboration and capability together — for the companies building the science, and the investors backing what it becomes.